openPR Logo
Press release

Overactive Bladder (OAB) Therapeutics Market to Register a Strong Growth By 2021 - Persistence Market Research

10-17-2016 11:45 AM CET | Health & Medicine

Press release from: Persistence Market Research Pvt. Ltd

Overactive Bladder (OAB) Therapeutics Market to Register

Overactive bladder is a medical syndrome, defined by urinary incontinence usually characterized by high urine frequency or nocturia. The common symptoms of OAB includes urgency, high urinary frequency and urge incontinence. Anticholinergic agents are considered as the first line treatment for overactive bladder disorders. Flavoxate, oxybutynin, tolterodine are some of the generic drugs used for the treatment of overactive bladder. These drugs acts by antagonizing cholinergic receptors that provides the relief from the frequent urination.

View Full Report@ http://www.persistencemarketresearch.com/market-research/overactive-bladder-therapeutics-market.asp

Increasing population diagnosed with overactive bladder disorder coupled with aging population will drive the growth of this market. Furthermore, manufacturers are continuously increasing their research and development expenditure to develop novel drugs such as neuromuscular blocking agents with innovative mechanism of actions. This factor will provide healthy platform to develop this market and hence drives the market growth. In addition, efforts of many key players launching consumer campaigns aiming to increase the awareness of this disorder among the people will further boost the growth of this market. However, patent expiry of the key drugs namely Oxytrol, Toviaz and Detrol may significantly restrain the growth of this market. Unfavorable side effect such as bladder muscle contraction, mental confusion, dry mouth and constipation coupled with low efficacy of available drugs will also restrain the growth of this market.

Geographically, North America is considered to be the largest market of overactive bladder therapeutics owing to introduction of advanced techniques for the treatment of these disorder. Europe is considered as second largest market of overactive bladder therapeutics. The growth is mainly attributed to widespread availability of generic drugs for the treatment of this disorder. In addition, Asia-Pacific region is the emerging markets for overactive bladder therapeutics market because of rising healthcare awareness among the people.

Request for Table of Content@ http://www.persistencemarketresearch.com/toc/5612

Various key players contributing to the global overactive bladder therapeutics market includes Allergan, Inc. , Antares Pharma, Inc , Astellas Pharma, Inc., Hisamitsu Pharmaceutical Co., Inc., Teva Pharmaceutical Industries Limited and others.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA - Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Overactive Bladder (OAB) Therapeutics Market to Register a Strong Growth By 2021 - Persistence Market Research here

News-ID: 373112 • Views:

More Releases from Persistence Market Research Pvt. Ltd

Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Market to Hit Surpass US$ 679.6 Million by 2032
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032. The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthetic Lasers Market
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism. Stay Ahead with Market Intelligence Get Free
Predictive Insights for Precision Medicine: The Global Biosimulation Market is Set to Hit USD 10 billion by 2030
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.  Market Overview The biosimulation market has experienced rapid growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheelchairs to Boost Growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961 The global wheelchair and components market has witnessed significant growth in

All 5 Releases


More Releases for Overactive

Overactive Bladder (OAB) - Drug Pipeline Landscape, 2022
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women. The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking. The most common symptoms
Overactive Bladder Treatment Market Size, Forecast Report 2022 - 2030
Acumen Research and Consulting has announced the addition of the "Overactive Bladder (OAB) Treatment Market" report to their offering. The Overactive Bladder (OAB) Treatment Market Report 2030 is an in depth study analyzing the current state of the Overactive Bladder (OAB) Treatment Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Overactive Bladder (OAB) Treatment Market provides analysis
US Overactive Bladder Market Analysis with Research Report 2020
The US Overactive Bladder Market research study is segmented on the basis of applications, technology, geography and types. The report provides a detailed Overactive Bladder Industry Overview along with the analysis of industry's gross margin, cost structure, consumption value, and sale price. The leading companies of the Overactive Bladder Market, manufacturers, and distributors are profiled in the report along with the latest Industry development current and future trends. The U.S. OAB
Overactive Bladder (OAB) Treatment- Global Market Outlook 2019-2024
Global Overactive Bladder Treatment Market, delivering a must-read report for industry stakeholders wanting to understand the strategic landscape of this burgeoning sector. Readers will find an in-depth analysis of the market and how it will impact existing traditional markets, as well as insights into future development and opportunities across the globe. MarketInsightsReports has announced the addition of the "Global Overactive Bladder Treatment Market Research Report 2018" The report focuses on global
Overactive Bladder Treatment Market-entry and market expansion strategies
MarketResearchReports.Biz adds “Global Overactive Bladder Treatment Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Overactive Bladder Treatment market and the growth estimates for the forecasted period. Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of
Global Overactive Bladder Drug Market - A Detailed Growth Analysis
Qyresearchreports include new market research report Global Overactive Bladder Drug Market Size, Status and Forecast 2022 to its huge collection of research reports. The report on the global Overactive Bladder Drug market offers a comprehensive insight into the current market outlook, emerging demand dynamics, share and size of various segments, and the competitive landscape. The elaborate analysis of the Overactive Bladder Drug market includes an assessment of various business risks, particularly